Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
Have you forgotten your password?
Home
College of Medicine / 醫學院
School of Medicine / 醫學系
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply
Details
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply
Journal
The New England journal of medicine
Journal Volume
383
Journal Issue
7
Date Issued
2020
Author(s)
Finn R.S.
ANN-LII CHENG
DOI
10.1056/NEJMc2021840
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089408058&doi=10.1056%2fNEJMc2021840&partnerID=40&md5=67a70000732082a763df58fc979e037b
https://scholars.lib.ntu.edu.tw/handle/123456789/580021
SDGs
[SDGs]SDG3
Publisher
NLM (Medline)
Type
letter